Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Chemistry

Medicine

Pathology

Show all topics

DOI

10.1101/2024.03.20.585861

License

CC-BY-NC

Other Formats

PDF